Forty-five million people in the U.S. speak Spanish as their dominant language. The cannabis industry has existed legally for over a decade. And it took until 2026 for one of the country’s largest dispensary chains to build a full Spanish-language experience for them. Curaleaf finally did it. Took a minute.
The program rolled out this month across Curaleaf’s 73 medical cannabis dispensaries in Florida. It covers in-store kiosks in Spanish, a fully translated curaleaf.com, a Spanish SWEED e-commerce storefront, printed bilingual education materials, and paid media built for Spanish-speaking audiences. Curaleaf says it plans to scale the model to other states and other languages.
If you are wondering why this took so long, you are not the only one.
The math the industry kept ignoring
The U.S. Census Bureau pegs the country’s Hispanic population at 68 million as of 2024, one in five Americans. Data compiled by the Cervantes Institute and reported by Euronews earlier this year put the number of dominant Spanish speakers (monolingual and bilingual) at at least 45 million, with another 15 million at varying levels of fluency. That makes the United States the second-largest Spanish-speaking country in the world. Only Mexico has more.
Florida is one of the densest pockets of that map. 6.7 million Hispanics, 28.7% of the state’s population. It is also one of the largest medical cannabis markets in the country, with close to a million registered patients.
The arithmetic was never the hard part. The hard part was getting a major operator to actually move on it.
The budtenders called it
The initiative did not come out of a strategy deck. It came out of the retail floor.
Justin Miller, Senior Vice President of Brand Marketing at Curaleaf, told High Times the program was triggered by feedback from the staff who actually deal with patients every day.
“This initiative started with our budtenders telling us there were people walking into our stores who weren’t able to access the full Curaleaf retail experience in their primary language. That’s the kind of feedback you have to act on.”
Justin Miller, Curaleaf
That is the cleanest signal a brand ever gets. Not a survey. Not a focus group. The person at the counter, listening to the same conversation over and over.
Cultural translation, not Google Translate
This is where most attempts at Spanish-language brand programs fall apart. They run English copy through a translator, slap it on the same template, and call it done. The patient opens the page and immediately knows it was not built for them.
Miller was clear that Curaleaf took a different route.
“Curaleaf’s approach was deliberately built around cultural fluency, not just language conversion.”
Justin Miller, Curaleaf
In practice, that meant three things. Legal and regulatory copy (THC warnings, mandatory product disclosures) got professionally translated and certified, because mistakes there carry real consequences. Brand and product names, including strain names, run on locked glossaries so the core identity stays consistent even as the surrounding copy adapts. And the marketing copy, offers, calls to action, and educational content all got rewritten with local tone and idiom, instead of converted word-for-word.
Curaleaf also pulled in internal Spanish speakers to vet tone and cultural nuance. Miller named Angel Rodriguez, the company’s SVP of HR and a native Spanish speaker, as a key voice in the review process.
Why Florida first
Curaleaf operates 73 medical dispensaries in Florida. That alone makes the state the natural pilot.
“Florida felt like the right place to prove this out, given how large and important the Spanish-speaking community is here.”
Justin Miller, Curaleaf
The plan is to use Florida as a template. If the model holds, Curaleaf will replicate it in other states and eventually in other languages.
The early feedback is reportedly positive. Miller said physicians and medical-card providers across Florida have told the company they have not seen anything like this in the market, and that their patients are visibly happy to have Spanish-language materials for the first time.
For new patients, Curaleaf is offering a 60% discount on the first three visits. The educational handouts circulating in dispensaries include a Cannabis 101 piece titled “Bienvenido al Cannabis,” covering how the plant works, THC and CBD basics, product types, dosing, onset and duration. There is also a Florida-specific guide explaining the three steps to get a medical card in the state. None of this is groundbreaking on its own. What is new is that it exists at scale, in Spanish, inside a major operator’s full retail and digital stack.
Curaleaf’s pitch describes the program as the first of its kind from a major MSO. That claim deserves a sober look.
Other operators have done bilingual work before. Happy Munkey, the New York dispensary built on a Latino-led brand identity, has a Spanish-language presence in its stores. Other state-level operators have rolled out Spanish signage and materials to varying degrees. What Curaleaf is claiming is narrower. Asked to be precise, Miller said it like this:
“This is the first time a major multi-state operator has built a fully integrated, end-to-end Spanish-language experience spanning retail, e-commerce, digital and media, with a defined plan to scale it nationally.”
Justin Miller, Curaleaf
That is the honest version. And at MSO scale, in legal U.S. cannabis, no other operator currently has anything comparable.
What this means for the rest of the industry
Curaleaf operates in 17 U.S. states and has international operations in Europe, Canada and Australasia. The company closed Q1 2026 with $324 million in revenue and $70 million in net income. In April, it completed the buyout of Germany’s Four 20 Pharma, an EU-GMP and GDP licensed producer. The Spanish-language program slots into a broader market-localization strategy.
Miller hedged on projections. The company is treating this like any new-market expansion: start with a strong base in Florida, measure engagement, refine, then scale.
Here is the part that should make every other MSO uncomfortable. The U.S. cannabis industry has had more than a decade to build for Spanish-speaking patients. The data on Hispanic consumers, Florida patient populations, Latino purchasing power and bilingual retail performance have been sitting on every operator’s desk that whole time. The market did not change. The marketing did not change. Until now.
Curaleaf got there first. Later than we expected, but first. The next question is which competitor moves second, and how long the others wait before they have to explain to their boards why they ignored 45 million potential customers.
